HPE Human albumin handbook | Page 6

Can be used as replacement or maintenance fluids Crystalloids can be used as both replacement and maintenance fluids . Meta-analyses and systematic reviews have shown that crystalloids are effective in fluid resuscitation in septic and critically ill patients . 5 , 6 , 8 If used appropriately according to individual maintenance fluid requirements , crystalloid solutions can effectively maintain fluid and electrolyte balance . 4
However , it should be noted that crystalloids are not indicated for volume replacement in all clinical settings . According to recommendations of the Surviving Sepsis Campaign Guidelines and the European Society of Intensive Care Medicine , the use of albumin is advocated for fluid resuscitation in patients with severe sepsis , particularly if they
10 , 11 require large amounts of fluid . Similarly , crystalloids might not always be the best choice for volume resuscitation in cases of cardiac surgery due to the potential for fluid overload .
Cons The comparative ‘ cons ’ of crystalloids are due to their inherent pharmacological properties . As long as crystalloids are used in a considered manner , alongside colloids ( if appropriate ), then these pharmacological properties can be exploited for their clinical utility .
Potential for fluid and electrolyte overload Crystalloids pass rapidly and freely across capillary membranes and equilibrate within the entire extracellular fluid space . Therefore , retention of a crystalloid within the intravascular space is poor . To replace a given volume of blood loss requires at least three times more crystalloid volume . As 75 – 80 % of the infused crystalloid volume will remain in the extravascular space , 12 fluid replacement with crystalloids is associated with an increased level of tissue hydration and risk of oedema : specifically , increased extravascular lung water and peripheral tissue oedema . Peripheral tissue oedema can affect wound healing and is uncomfortable for the patient , potentially making mobilisation more difficult . Oedema adversely affects the transport of oxygen and nutrients to tissue cells , potentially impairing organ function . Fluid overload with crystalloids can result in an increase in the fluid content of vital organs , including a delay in the return of normal gastrointestinal motility . In elderly patients with reduced functional respiratory and cardiovascular function , this can also result in significant morbidity and mortality . 3 In such situations , fluids with a high volume effect , such as albumin , should be considered instead for volume resuscitation . 13 If large volumes of crystalloids with high chloride content , particularly sodium chloride 0.9 %, are given in an attempt to restore the circulating volume , there is a risk of hypochloraemic acidosis . This , then , causes renal vasoconstriction and reduced glomerular filtration rate . In catabolic surgical patients , this is further compounded by increased urea production and the inflammatory response to surgery , resulting in a large proportion of sodium , chloride and water being retained within the interstitial space . Hence , there is a need for a balanced fluid replacement regimen , ensuring that an excessive quantity of neither fluid nor electrolytes are administered . Crystalloids are adequate for fluid resuscitation but lack additional beneficial properties provided by fluids such as albumin .
Potential for adverse respiratory effects If an excessive amount of dextrose is administered , particularly in critically ill , ventilator-dependent patients , an enhanced production of carbon dioxide and lactate may result . In addition , dextrose should not be used in isolation to treat hypovolaemia , as it only provides free water and does not replace electrolytes .
Lack of additional biochemical properties Crystalloids do not have any additional biochemical properties , with their action being only to provide fluid and , depending on the solution administered , electrolytes .
Conclusions Crystalloids are inexpensive , readily available intravenous solutions for the replacement and maintenance of fluid requirements . However , they should be prescribed in a considered approach tailored to individual patients ’ fluid requirements and clinical condition to avoid excessive fluid and electrolyte administration and subsequent effects on morbidity and mortality . A balanced fluid regimen should be administered incorporating a combination of different crystalloids and colloids , if indicated . Individual solution choices should reflect the current evidence-base . Education of the entire multi-disciplinary team regarding the appropriate use of crystalloids within a balanced fluid regimen is essential to ensure that practice is consistent and informed by consensus guidelines .
References 1 Awad S , Allison SP , Lobo DN . The history of 0.9 % saline . Clin Nutr 2008 ; 27:179 – 88 . 2 Lobo DN et al . Problems with solutions : drowning in the brine of an inadequate knowledge base . Clin Nutr 2001 ; 20:125 – 30 . 3 Callum KG et al . Extremes of Age : The 1999 Report of the National Confidential Enquiry into Perioperative Deaths : London : NCEPOD , 1999 . 4 Powell-Tuck J et al . British
Consensus Guidelines on Intravenous Fluid Therapy for Adult Surgical Patients ( GIFTASUP ). BAPEN Medical , 2011 . www . bapen . org . uk / pdfs / bapen _ pubs / giftasup . pdf ( accessed June 2019 ). 5 Perel P , Roberts I , Ker K . Colloids versus crystalloids for fluid resuscitation in critically ill patients . Cochrane Database Syst Rev 2013 ; 2 : CD000567 . doi : 10.1002 / 14651858 . CD000567 . pub6 .
6 Bisonni RS et al . Colloids versus crystalloids in fluid resuscitation : an analysis of randomized controlled trials . J Fam Pract 1991 ; 32:387 – 90 . 7 Skellett S et al . Chasing the base deficit : hyperchloraemic acidosis following 0.9 % saline . Arch Dis Child 2000 ; 83:514 – 6 . 8 Haase N et al . Hydroxyethyl starch 130 / 0.38-0.45 versus crystalloid or albumin in patients with sepsis : systematic review with meta-analysis and
trial sequential analysis . BMJ 2013 ; 346 : f839 9 McClelland DBM ( ed ). Handbook for Transfusion Medicine ( 4th edition ). UK Blood Services , TSO Norwich , 2007 . 10 Rhodes A et al . Surviving Sepsis Campaign : International Guidelines for Management of Sepsis and Septic Shock : 2016 . Intensive Care Med 2017 ; 43 : 304 – 77 . 11 Reinhart K et al . Consensus statement of the ESICM task
force on colloid volume therapy in critically ill patients . Intens Care Med 2012 ; 38:368 – 83 . 12 Halijame H . Use of fluids in trauma . Int J Intens Care 1999 ; 6:20 . 13 Jacob M et al . The intravascular effect of Ringer ’ s lactate is below 20 %: a prospective study in humans . Crit Care 2012 ; 16 : R86 .
6 | 2019 | hospitalpharmacyeurope . com